Fox Chase Cancer Center: Case Study Shows That Drug Sensitivity Testing Could Help Personalize Chronic Lymphocytic Leukemia Treatment Selection
May 27, 2023
May 27, 2023
PHILADELPHIA, Pennsylvania, May 27 (TNSjou) -- The Fox Chase Cancer Center, a part of Temple Health, issued the following news release on May 26, 2023:
Management of chronic lymphocytic leukemia (CLL) is a rapidly evolving field, so choosing between the growing number of effective, available therapies can be challenging for both physicians and patients.
Researchers at Fox Chase Cancer Center have developed a model that mimics patients' tumor microenvironment that t . . .
Management of chronic lymphocytic leukemia (CLL) is a rapidly evolving field, so choosing between the growing number of effective, available therapies can be challenging for both physicians and patients.
Researchers at Fox Chase Cancer Center have developed a model that mimics patients' tumor microenvironment that t . . .